期刊文献+

糖胰康改善成人隐匿性自身免疫性糖尿病胰岛β细胞功能的临床研究 被引量:6

Effect of Tangyikang in Improving the Function of Pancreatic Islet β Cells in Patients with Latent Autoimmune Diabetes Mellitus in Adults
下载PDF
导出
摘要 目的探讨糖胰康对成人隐匿性自身免疫性糖尿病(latent autoimmune diabetes mellitus in adults,LADA)胰岛β细胞功能的改善作用与机制。方法将74例LADA患者随机分为两组,治疗组37例采用糖胰康(由红参10g黄芪30g麦冬15g知母10g黄连15g栀子10g虎杖10g红花10g牡丹皮10g组成)水煎剂口服加胰岛素治疗;对照组37例采用单纯胰岛素治疗;疗程均为3个月。观察两组治疗前后糖化血红蛋白(HbA1c)、胰岛β细胞功能指标(△CP2h/△BS2h)、血清γ干扰素(IFN-γ)和白细胞介素-4(IL-4)的变化。结果两组各指标均较治疗前改善。两组治疗后HbA1c比较,差异无统计学意义(t=0.441,P=0.660);△CP2h/△BS2h治疗组(0.258±0.106)较对照组(0.168±0.054)改善明显(t=4.626,P<0.01);胰岛素用量治疗组少于对照组(t=-4.169,P<0.01);协方差分析排除两组胰岛素用量不同的影响,治疗组较对照组IL-4升高(F=24.217,P<0.01),IFN-γ下降(F=14.198,P<0.01)。结论糖胰康有改善LADA患者胰岛β细胞功能的作用,其机制与调节细胞免疫,纠正Th1/Th2亚群失衡有关。 Objective To investigate the effect and mechanism of Tangyikang (TYK) for improving pancreatic islet β cell function in patients with latent autoimmune diabetes mellitus in adults (LADA). Methods Seventyfour LADA patients were randomly assigned to two groups. The 37 patients in the treatment group were treated with TYK decoction (one dose consisted of red ginseng 10 g, milkvetch root 30 g, lilyturf root 15 g, wild weed 10 g, coptis root 15 g, cape-jasmine fruit 10 g, giant knotweed rhizome 10 g, safflower 10 g and moutan bark 10 g) combined with insulin therapy, and the 37 in the control group treated with insulin therapy alone, and the course for all was 3 months. Changes of glycosylated hemoglobin, index of pancreatic islet β-cell function ( G CP2h/A BS2h) , serum interferon-γ (IFN-γ) and interleukin- 4 (IL-4) were observed before and after treatment. Results All the above-mentioned indexes were improved after treatment in both groups, the post-treatment data showed significant difference between groups in △ CP2h/△ BS2h (0. 258 ± 0. 106 vs 0. 168 ± 0. 054, higher in the treatment group, t = 4. 626,P 〈 0. 01 ) , but with insignificant difference in glycosylated hemoglobin (t = 0. 441, P = 0. 660). Besides, the dosage of insulin used in the treatment group was less than that in the control group (t = - 4. 169, P 〈 0.01) ; covariance analysis showed, through excluding impact of different dosages insulin used, IL- 4 level was higher (F = 24. 217, P 〈0.01 ) and IFN-γ level was lower ( F = 14. 198, P 〈0.01 ) in the treatment group than those in the control group. Conclusions TYK could improve the function of islet β-cell, its possible mechanism is related with the regulation on cell immunity and the correction of T-lymphocyte subsets (Th1/Th2 ratio) imbalance.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第10期882-885,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 青岛市中医管理局2003年基金项目(No.2003-zyy012)
关键词 糖尿病 自身免疫型 糖胰康 胰岛功能 diabetes mellitus autoimmune Tangyikang islet function
  • 相关文献

参考文献15

  • 1Kobayashi T, Nakanishi K, Murase T, et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996 ;45 ( 5 ) : 622-626.
  • 2WHO Consultation Group. Definition, diagnosis and classification of diabetes mellitus and its complications. 2nd ed. Part 1 : Diagnosis and classification of diabetes mellitus WHO/NCD/ NCS/99. Geneva: World Health Organization, 1999: 1-59.
  • 3周智广,伍汉文.成人隐匿性自身免疫性糖尿病的诊断与治疗[J].中华内分泌代谢杂志,1998,14(1):1-2. 被引量:98
  • 4Fourlanos S, Dotta F, Greenbaum C J, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005 ; 48 ( 11 ) : 2206-2212.
  • 5张惠芬 迟家敏 等.实用糖尿病学[M].北京:人民卫生出版社,2001.293.
  • 6李霞,周智广,黄干,彭健,颜湘,王建平,杨琳.罗格列酮与胰岛素合用对LADA患者胰岛β细胞功能保护作用的初步观察[J].中国糖尿病杂志,2003,11(4):242-246. 被引量:63
  • 7何凌,周智广,罗建华,黄干,裴剑浩,王建平,邓志明,李莉蓉,张弛,杨晓琳.LADA患者Th1/Th2细胞因子水平的变化[J].实用医学杂志,2004,20(9):980-982. 被引量:5
  • 8Katz JD, Benosit C, Mathis D, et al. T helper cell subsets in insulin-dependent diabetes. Science 1995 ; 268 ( 5214 ) : 1185-1188.
  • 9Kobayasbi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve beta-cells in slowly progressive insulin-dependent ( type 1 ) diabetes mellitus. Ann NY Acad Sci 2002 ; 958: 117-130.
  • 10陈蔚,刘芳,俞茂华,朱秋毓,朱禧星.黄芪多糖对NOD小鼠1型糖尿病的预防作用[J].复旦学报(医学版),2001,28(1):57-60. 被引量:34

二级参考文献41

  • 1赵克胜,丁丽轩,孔海燕,田淑媛,金伯泉,刘雪松.黄芪多糖增强人外周血单个核细胞产生肿瘤坏死因子的研究[J].中国中西医结合杂志,1993,13(5):263-265. 被引量:34
  • 2储钟禄,姜云飞,王智慧,宋春桥,徐志平.黄连素对血小板聚集和释放的抑制作用[J].第二军医大学学报,1989,10(4):323-327. 被引量:17
  • 3范少光,丁桂凤.神经内分泌与免疫系统之间相互作用的介导物质:共用的生物学语言[J].生理科学进展,1995,26(2):175-183. 被引量:100
  • 4王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 5[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80.
  • 6[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459.
  • 7[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189.
  • 8[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249.
  • 9[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626.
  • 10[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130.

共引文献271

同被引文献98

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部